Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.

[1]  S. Stratford.  Regulation of insulin action by ceramide : dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase , 2004 .

[2]  G. Shulman,et al.  Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.

[3]  N. Ruderman,et al.  Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α , 2002 .

[4]  R. Thieringer,et al.  11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice , 2005, The Journal of experimental medicine.

[5]  S. Summers,et al.  A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. , 2005, Diabetes.

[6]  A. Merrill,et al.  Two Mammalian Longevity Assurance Gene (LAG1) Family Members, trh1 and trh4, Regulate Dihydroceramide Synthesis Using Different Fatty Acyl-CoA Donors* , 2003, Journal of Biological Chemistry.

[7]  G. Shulman,et al.  PKC-theta knockout mice are protected from fat-induced insulin resistance. , 2004, The Journal of clinical investigation.

[8]  M. Rekhter,et al.  Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice , 2004, Circulation.

[9]  G. Shulman,et al.  Fatty Acid Infusion Selectively Impairs Insulin Action on Akt1 and Protein Kinase C λ/ζ but Not on Glycogen Synthase Kinase-3* , 2002, The Journal of Biological Chemistry.

[10]  M. Lorenzo,et al.  Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. , 2001, Diabetes.

[11]  G. Shulman,et al.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.

[12]  G. Cooney,et al.  Peroxisome Proliferator—Activated Receptor (PPAR)-α Activation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat—Fed Rats Comparison With PPAR-γ Activation , 2001 .

[13]  D. Brindley,et al.  Effects of Cell-Permeable Ceramides and Tumor Necrosis Factor-α on Insulin Signaling and Glucose Uptake in 3T3-L1 Adipocytes , 1998, Diabetes.

[14]  C. Schmitz‐Peiffer.  Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. , 2000, Cellular signalling.

[15]  F. Liu,et al.  Regulation of Insulin Action by Ceramide , 2004, Journal of Biological Chemistry.

[16]  M. Wakelam.  Diacylglycerol--when is it an intracellular messenger? , 1998, Biochimica et biophysica acta.

[17]  R. DeFronzo,et al.  Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. , 2004, Diabetes.

[18]  B. Saltin,et al.  Exercise and training effects on ceramide metabolism in human skeletal muscle , 2004, Experimental physiology.

[19]  G. Cooney,et al.  Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. , 2001, Diabetes.

[20]  H. Beck-Nielsen,et al.  Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes. , 2005, Diabetes.

[21]  R. Dobrowsky,et al.  A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids* , 2003, The Journal of Biological Chemistry.

[22]  A. Dobrzyń,et al.  Effect of endurance training on the sphingomyelin-signalling pathway activity in the skeletal muscles of the rat. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[23]  S. Summers,et al.  Ceramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocation. , 2001, The Biochemical journal.

[24]  Alfred H. Merrill,et al.  De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway* , 2002, The Journal of Biological Chemistry.

[25]  É. Hajduch,et al.  Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. , 2004, The Biochemical journal.

[26]  J. McGarry,et al.  The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. , 1997, The Journal of clinical investigation.

[27]  É. Hajduch,et al.  Ceramide Disables 3-Phosphoinositide Binding to the Pleckstrin Homology Domain of Protein Kinase B (PKB)/Akt by a PKCζ-Dependent Mechanism , 2003, Molecular and Cellular Biology.

[28]  J. McGarry.  Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.

[29]  A. Rivellese,et al.  Quality of dietary fatty acids, insulin sensitivity and type 2 diabetes. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  Yusuf A. Hannun,et al.  The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind* , 2002, The Journal of Biological Chemistry.

[31]  Dan R. Littman,et al.  PKC-θ knockout mice are protected from fat-induced insulin resistance , 2004 .

[32]  N. Ruderman,et al.  Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. , 2002, Diabetes.

[33]  G. Hotamisligil,et al.  Inflammatory pathways and insulin action , 2003, International Journal of Obesity.

[34]  M. Hojjati,et al.  Effect of Myriocin on Plasma Sphingolipid Metabolism and Atherosclerosis in apoE-deficient Mice* , 2005, Journal of Biological Chemistry.

[35]  J. Flier,et al.  A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.

[36]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[37]  G. Reaven.  The insulin resistance syndrome: definition and dietary approaches to treatment. , 2005, Annual review of nutrition.

[38]  I. Batty,et al.  Ceramide impairs the insulin-dependent membrane recruitment of Protein Kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells , 2001, Diabetologia.

[39]  C. Sung,et al.  Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance. , 2002, American journal of physiology. Endocrinology and metabolism.

[40]  Scott A Summers,et al.  Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. , 2003, Archives of biochemistry and biophysics.

[41]  Christophe Person,et al.  Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells , 1998, Nature.

[42]  S. Summers,et al.  Measuring insulin-stimulated phosphatidyl-inositol 3-kinase activity. , 2003, Methods in molecular medicine.

[43]  C. Edwards,et al.  Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. , 1999, The Journal of clinical investigation.

[44]  S. Summers,et al.  Acid Ceramidase Overexpression Prevents the Inhibitory Effects of Saturated Fatty Acids on Insulin Signaling* , 2005, Journal of Biological Chemistry.

[45]  S. Olshansky,et al.  A potential decline in life expectancy in the United States in the 21st century. , 2005, The New England journal of medicine.

[46]  Edwards,et al.  11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress , 1997 .

[47]  J. Flier,et al.  Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. , 2003, The Journal of clinical investigation.

[48]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[49]  D. O'sullivan,et al.  1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. , 1990, The Journal of biological chemistry.

[50]  I. Kowalska,et al.  Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. , 2004, Diabetes.

[51]  M. Birnbaum,et al.  Insulin, but Not Contraction, Activates Akt/PKB in Isolated Rat Skeletal Muscle* , 1998, The Journal of Biological Chemistry.

[52]  A. Dobrzyń,et al.  Effect of streptozotocin-diabetes on the functioning of the sphingomyelin-signalling pathway in skeletal muscles of the rat. , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[53]  Honglin Zhou,et al.  Regulation of Insulin-Stimulated Glucose Transporter GLUT4 Translocation and Akt Kinase Activity by Ceramide , 1998, Molecular and Cellular Biology.